Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 5/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 4/20 | 0.35 |
| ▸ | ACHE | P22303 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Styrene SCHEMBL3958178 | 0.97 | KDM4E (0.39) | KDM4ETDP1TSHRL3MBTL1HPGD | |
| Ethyl Fumarate SCHEMBL250291 | 0.92 | HCAR2 (0.44) | KDM4ETDP1L3MBTL1ATMAPP | |
| Styrene SCHEMBL2061795 | 0.92 | ALDH1A1 (0.39) | KDM4ETDP1TSHRL3MBTL1HPGD | |
| Styrene SCHEMBL8844775 | 0.88 | KMT2A (0.48) | KDM4ETSHRL3MBTL1HPGDALDH1A1 | |
| SCHEMBL17746645 | 0.88 | KDM4E (0.43) | KDM4ETDP1TSHRL3MBTL1APP | |
| Styrene SCHEMBL522764 | 0.85 | KDM4E (0.49) | KDM4ETDP1TSHRL3MBTL1APP | |
| Styrene SCHEMBL250640 | 0.85 | HCAR2 (0.47) | KDM4ETDP1TSHRL3MBTL1HPGD | |
| Styrene SCHEMBL251244 | 0.85 | HCAR2 (0.38) | KDM4ETDP1TSHRL3MBTL1HCAR2 | |
| SCHEMBL2259513 | 0.85 | ATM (0.50) | TDP1TSHRL3MBTL1HPGDATM | |
| Acrylonitrile SCHEMBL295503 | 0.85 | KDM4E (0.47) | KDM4ETDP1TSHRL3MBTL1APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 655 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200301296-A1 | EMULSION AGGREGATION PROCESS | XEROX CORPORATION | 2020-09-24 | — | — | US | claimed |
| EP-3266908-B1 | ANTI-BACTERIAL METALLO IONOMER POLYMER NANOCOMPOSITE FILAMENTS AND METHODS OF MAKING THE SAME | XEROX CORP (US) | 2020-05-06 | — | — | EP | claimed |
| US-10570290-B2 | Anti-bacterial aqueous ink compositions comprising metal ion composite ionomer resins | XEROX CORPORATION (US) | 2020-02-25 | — | — | US | claimed |
| EP-3266613-B1 | ANTI-BACTERIAL METALLO IONOMER POLYMER COMPOSITE POWDERS AND METHODS OF MAKING THE SAME | XEROX CORP (US) | 2019-10-16 | — | — | EP | claimed |
| US-10405540-B2 | Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same | XEROX CORPORATION (US) | 2019-09-10 | — | — | US | claimed |
| US-10113059-B2 | Anti-bacterial metallo ionomer polymer nanocomposite powders and methods of making the same | XEROX CORPORATION (US) | 2018-10-30 | — | — | US | claimed |
| US-10067434-B2 | Emulsion aggregation toners | XEROX CORPORATION (US) | 2018-09-04 | — | — | US | claimed |
| US-10018931-B2 | Toner compositions with optimized beta-carboxyethyl acrylate shell latex for improved particle formation and morphology | XEROX CORPORATION (US) | 2018-07-10 | — | — | US | claimed |
| US-10007200-B2 | Antimicrobial toner | XEROX CORPORATION (US) | 2018-06-26 | — | — | US | claimed |
| US-10007205-B2 | Styrene acrylate hybrid toner process utilizing a low VOC (volatile organic compound) coalescent agent in toner shells | XEROX CORPORATION (US) | 2018-06-26 | — | — | US | claimed |
| US-5962179-A | EXCELLENT TRIBOELECTRIC CHARGING CHARACTERISTICS AND WHICH TONERS CAN POSSESS HIGH IMAGE GLOSS, AND EXCELLENT IMAGE FIX AT LOW FUSING TEMPERATURES. | XEROX CORPORATION (US) | 1999-10-05 | — | — | US | claimed |
| EP-0928994-A2 | Toner preparation processes | Xerox Corporation (US) | 1999-07-14 | — | — | EP | claimed |
| US-5869215-A | Toner compositions and processes thereof | XEROX CORPORATION (US) | 1999-02-09 | — | — | US | claimed |
| US-5869216-A | LATEX, AGGREGATION, FUSION/COALESCENCE, SURFACE TREATMENT WITH A SALICYLIC ACID OR A CATECHOL | XEROX CORPORATION (US) | 1999-02-09 | — | — | US | claimed |
| US-5858601-A | Toner processes | XEROX CORPORATION (US) | 1999-01-12 | — | — | US | claimed |
| US-5827633-A | Toner processes | XEROX CORPORATION (US) | 1998-10-27 | — | — | US | claimed |
| US-5763133-A | Toner compositions and processes | XEROX CORPORATION (US) | 1998-06-09 | — | — | US | claimed |
| US-5747215-A | Toner compositions and processes | XEROX CORPORATION (US) | 1998-05-05 | — | — | US | claimed |
| EP-0522233-B1 | Impact resistant graft copolymers | HIMONT INC (US) | 1995-06-07 | — | — | EP | claimed |
| EP-0522233-A1 | Impact resistant graft copolymers | Himont Incorporated (US) | 1993-01-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10113059-B2 | Anti-bacterial metallo ionomer polymer nanocomposite powders and methods of making the same | RPN1, RPN2, MSH2 | KDM4E 3915/4885TDP1 3345/4885TSHR 4205/4885 |
| US-10405540-B2 | Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same | TERB1, NBAS, MFAP1 | KDM4E 4082/4885TDP1 2803/4885TSHR 4098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.